WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Recruiting

Conditions: Malignant Peripheral Nerve Sheath Tumors

First Posted Date: 2017-05-04

Last Posted Date: 2023-11-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1050

Registration Number: NCT03141021

Locations: 🇮🇳
Global Gene Corporation, Mumbai, India
🇬🇧
Royal National Orthopedic Hospital, London, United Kingdom
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 9 locations

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Phase 1

Recruiting

Conditions: Severe Sickle Cell Disease
Bone Marrow Failure Syndromes
Metabolic Disorders
Immunologic Disorders
Hemoglobinopathies
Non-malignant Disorders

Interventions: Drug: RIC regimen
Drug: GVHD prophylaxis regimen

First Posted Date: 2017-04-26

Last Posted Date: 2024-07-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 29

Registration Number: NCT03128996

Locations: 🇺🇸
Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Phase 1

Terminated

Conditions: Cancer of the Pancreas
Pancreas Cancer
Pancreatic Cancer

Interventions: Biological: Personalized neoantigen DNA vaccine
Device: TDS-IM Electrode Array System
Procedure: Peripheral blood draws

First Posted Date: 2017-04-20

Last Posted Date: 2023-10-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT03122106

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Phase 1

Terminated

Conditions: Follicular Lymphoma

Interventions: Biological: Personalized tumor vaccine
Drug: Poly ICLC
Biological: Nivolumab
Procedure: Peripheral blood draws
Procedure: Leukapheresis
Biological: Rituximab
Procedure: Biopsy

First Posted Date: 2017-04-20

Last Posted Date: 2023-08-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4

Registration Number: NCT03121677

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells

Terminated

Conditions: Urethra Injury
Catheter Site Discomfort

Interventions: Other: urine collection
Other: Blood collection
Behavioral: NRS

First Posted Date: 2017-04-18

Last Posted Date: 2018-11-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 58

Registration Number: NCT03118284

Locations: 🇺🇸
Washington University in St Louis, Saint Louis, Missouri, United States

Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant

Phase 1

Withdrawn

Conditions: HIV-1-infection

Interventions: Procedure: Peripheral blood draw

First Posted Date: 2017-04-18

Last Posted Date: 2018-11-07

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03118661

Intervention to End Recurrent Unscheduled Bleeding Trial

Phase 3

Completed

Conditions: Contraception
Bleeding

Interventions: Drug: Ulipristal Acetate
Drug: Placebo oral capsule

First Posted Date: 2017-04-18

Last Posted Date: 2018-08-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT03118297

Locations: 🇺🇸
Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States

CLA and Vitamin D on Protein Turnover

Not Applicable

Completed

Conditions: Protein

Interventions: Dietary Supplement: Conjugated linoleic acid and Vitamin D
Other: Corn oil (placebo)
Dietary Supplement: Vitamin D
Dietary Supplement: Conjugated linoleic acid

First Posted Date: 2017-04-14

Last Posted Date: 2019-11-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT03115775

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Effect of Biliopancreatic Diversion on Glucose Homeostasis

Not Applicable

Completed

Conditions: Obesity, Morbid

Interventions: Procedure: Biliopancreatic Diversion Surgery
Procedure: Roux-en-Y Gastric Bypass Surgery

First Posted Date: 2017-04-13

Last Posted Date: 2017-04-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 24

Registration Number: NCT03111953

Locations: 🇮🇹
Catholic University of the Sacred Heart, Rome, Italy

Postoperative Delirium: Brain Vulnerability and Recovery

Not Applicable

Completed

Conditions: Delirium
Postoperative Complications

Interventions: Device: EEG
Device: fcDOT
Device: fcMRI

First Posted Date: 2017-04-12

Last Posted Date: 2020-06-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 91

Registration Number: NCT03110185

Locations: 🇺🇸
Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy